Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2020. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3782431014 | Product containing precisely surface antigen of Hepatitis B virus 20 microgram/1 milliliter conventional release suspension for injection (clinical drug) | en | Fully specified name | Active | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
| 3782432019 | Hepatitis B virus surface antigen 20 microgram/mL suspension for injection | en | Synonym (core metadata concept) | Active | Entire term case sensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing precisely surface antigen of Hepatitis B virus 20 microgram/1 milliliter conventional release suspension for injection (clinical drug) | Has concentration strength numerator value | 20 | false | Inferred relationship | Some | 1 | |
| Product containing precisely surface antigen of Hepatitis B virus 20 microgram/1 milliliter conventional release suspension for injection (clinical drug) | Count of base of active ingredient | 1 | false | Inferred relationship | Some | ||
| Product containing precisely surface antigen of Hepatitis B virus 20 microgram/1 milliliter conventional release suspension for injection (clinical drug) | Has manufactured dose form | Suspension for injection | false | Inferred relationship | Some | ||
| Product containing precisely surface antigen of Hepatitis B virus 20 microgram/1 milliliter conventional release suspension for injection (clinical drug) | Has concentration strength denominator unit | mL | false | Inferred relationship | Some | 1 | |
| Product containing precisely surface antigen of Hepatitis B virus 20 microgram/1 milliliter conventional release suspension for injection (clinical drug) | Has concentration strength numerator unit | mcg | false | Inferred relationship | Some | 1 | |
| Product containing precisely surface antigen of Hepatitis B virus 20 microgram/1 milliliter conventional release suspension for injection (clinical drug) | Has precise active ingredient | Antigen of Hepatitis B virus surface protein (substance) | false | Inferred relationship | Some | 1 | |
| Product containing precisely surface antigen of Hepatitis B virus 20 microgram/1 milliliter conventional release suspension for injection (clinical drug) | Has concentration strength denominator value | 1 | false | Inferred relationship | Some | 1 | |
| Product containing precisely surface antigen of Hepatitis B virus 20 microgram/1 milliliter conventional release suspension for injection (clinical drug) | Has basis of strength substance (attribute) | Antigen of Hepatitis B virus surface protein (substance) | false | Inferred relationship | Some | 1 | |
| Product containing precisely surface antigen of Hepatitis B virus 20 microgram/1 milliliter conventional release suspension for injection (clinical drug) | Is a | Product containing only surface antigen of Hepatitis B virus in parenteral dose form (medicinal product form) | false | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Concept inactivation indicator reference set
POSSIBLY EQUIVALENT TO association reference set (foundation metadata concept)
FHIR